Looking to publish in Infectious Diseases And Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowInfectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to high-quality clinical, observational, real-world, and health outcomes research on infectious disease therapies and interventions, including vaccines and devices. It also welcomes research on diagnostics, pharmacoeconomics, public health, epidemiology, quality of life, patient care, management, and education, and publishes original research, reviews, case reports, trial protocols, short communications, commentaries, editorials, and letters.
Looking to publish in Infectious Diseases And Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Infectious Diseases And Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Brief Report
Editorial
Letter to the Editor
Guideline
Recent Publications
Burden of Respiratory Syncytial Virus in Older ADults in Nagasaki, Japan (Nagasaki ROAD): Preliminary Results (April 2024–March 2025) of a Prospective, Multicenter, Epidemiological Study
Takahiro Takazono, Norihito Kaku, Naoki Hosogaya, Kiyoyasu Fukushima, Ryota Takao, Naoki Iwanaga, Takuya Izumikawa, Mai Kato, Kentaro Tajima, Yufan Ho, Katsunori Yanagihara, Hiroshi Mukae
Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review
Rui Ge, Xinwen Nian, Benjuan Liu, Yunyun Yang, Zhuo Wang
Modeling the Public Health Impact of Introducing 4CMenB Vaccination for Infants in the Brazilian National Immunization Program
Thatiana Pinto, Zeki Kocaata, Ana Medina, Igor Sampietri, Graziela Bernardino, Justyna Zawieja, Yaneth Gil-Rojas, Anna Tytuła, Maria Gabriela Graña, Elise Kuylen
Multicenter Real-World Outpatient Use of Intravenous Omadacycline
Lucinda J. Van Anglen, Cathy L. Koo, Kimberly A. Couch
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Curtis Cooper, Shweta A. Raina, Lisa Johnson, Jordan J. Feld, Ashley Brown, Anthony Martinez, Brian Conway, Stuart C. Gordon, Tarik Asselah, Liz Uribe, Moming Li, Alexandru Iacob, John Marcinak, Dimitri Semizarov, Stanislas Pol
Frequently asked questions
How long does it take to publish?
2-week peer review; 3-4 weeks from acceptance to online publication; submission to first decision median is 1 day.
Reformat to Infectious Diseases And Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required to highlight publication deadlines, trial registration details, open access choice for Advances in Therapy, and any relevant submission information.
Reformat to Infectious Diseases And Therapy using Livewrite PremiumWhat are the publication costs?
Mandatory Rapid Service Fee of €5950/$7675/£5120 upon acceptance; open access publication costs included.
Reformat to Infectious Diseases And Therapy using Livewrite Premium